<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20231207060287N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2024-01-28</date_registration>
      <primary_sponsor>Iran University of Medical Sciences</primary_sponsor>
      <public_title>Investigating the effects of physiotherapy on the treatment of post-Covid-19 syndrome complications</public_title>
      <acronym></acronym>
      <scientific_title>Comparing the effects of pulmonary rehabilitation interventions, whole body vibration and cognitive-behavioral therapy on fatigue, dyspnea, physical function and quality of life in people with post-COVID-19 syndrome. A randomized   clinical controlled trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2024-02-20</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>51</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/74278</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Factorial, Purpose: Supportive, Randomization description: In this study, we will use the restricted randomization method of the block balanced randomization type. In this method, the size of all the blocks is equal and we will have 6 blocks in this three-group experiment. The randomization tool is also used from random sequence generation software (Random allocation software), which in addition to simple randomization, these random sequence generation software are capable of generating random sequence by block method. For concealment, we use Concealment Allocation, which refers to the method used to perform a random sequence on the participants in the study, so that the allocated group is not known before the allocation of the individual. By using opaque, sealed, numbered sequentially envelopes, in this method, each random sequence created is recorded on a card, and the cards are inside the letter envelopes. They are placed in order. In order to maintain a random sequence, the outer surface of the envelopes is numbered in the same order. Finally, the lid of the letter envelopes is glued and placed in a box. At the time of starting the registration of participants, based on the order in which eligible participants entered the study, one of the envelopes will be opened and the assigned group of that participant will be revealed. The process of random allocation will be done by someone outside the research team and before the start of the study, and since the therapist is not aware of the allocation of groups until the implementation of the intervention, the important feature of allocation concealment of RCT studies is observed in this study, Blinding description: In this study, the researcher who is in charge of treating patients is blind, and the process of dividing and placing each person in different groups will be done by someone other than the therapist.
​.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Complications of post-COVID-19 syndrome including fatigue and shortness of breath.</hc_freetext>
      <i_freetext>Intervention 1: Control group: pulmonary rehabilitation. In this study, for pulmonary rehabilitation, we will use breathing exercises, stretching exercises and resistance exercises with elastic band along with encouragement to carry out care recommendations at home, during 6 weeks and 3 sessions per week.​. Intervention 2: The first intervention group: pulmonary rehabilitation with whole body vibration. In this study, for lung rehabilitation, we will use breathing exercises, stretching exercises and resistance exercises with an elastic band along with encouragement to carry out care recommendations at home, during 6 weeks and 3 sessions per week, and in addition to exercise the total tremor. The body is made of lanaform brand, POWER FULLS model and model number LA 57665, made in Belgium. Each whole body vibration training session consists of ten sets of one minute, using the device with a frequency of 35 Hz, after each one minute of using the device, the person rests for one minute. The whole body vibration training is done in 12 sessions twice a week in the morning. Intervention 3: The second intervention group: pulmonary rehabilitation with cognitive-behavioral therapy. In this study, we will use breathing exercises, stretching exercises and resistance exercises with an elastic band for pulmonary rehabilitation, along with encouraging to carry out care recommendations at home, during 6 weeks and 3 sessions per week, and in addition to cognitive behavioral therapy. Stark and Beck et al.'s model will be used. The sessions will be held in 6 weeks with 8 sessions (the first week (2 sessions), the second to fifth weeks (one session per week) and the last week (2 sessions)) for a duration of 45 minutes to one hour.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
The individual data of the participants without mentioning their names and addresses, the protocols carried out in the study, the way of statistical analysis, statistical codes, data coding systems, consent forms, questionnaires and registered clinical reports are documents that can have sharing
​

When:
Since the publication of the article and the publication of the results, access to the data is possible.
​

To whom:
All people in scientific institutions, universities and research centers will be allowed to access the documents.

Conditions:
If the documents are provided to qualified people, whose goal is to use the data for the development of scientific activities and treatment protocols.
​

Where to obtain:
To access the documents, people can contact the researcher's email at Fatemeh.menatnia@gmail.com.

How to obtain:
After receiving the request from the qualified people and providing the identity and scientific documents, the data files will be available to the applicants within one working week.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Fatemeh Menatnia</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Rehabilitation Sciences, Iran University of Medical Sciences, Shah Nazari St., Maddkaran St., Mader Square, Mirdamad, Tehran ​</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1341838771</zip>
        <telephone>+98 21 2226 9608</telephone>
        <email>fatemeh.menatnia@gmail.com</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Fatemeh Menatnia</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Rehabilitation Sciences, Iran University of Medical Sciences, Shah Nazari St., Maddkaran St., Mader Square, Mirdamad, Tehran ​</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1341838771</zip>
        <telephone>+98 21 2226 9608</telephone>
        <email>fatemeh.menatnia@gmail.com</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>People in the age range of 20 to 50 years                                People who have at least reading and writing literacy. (Having a primary degree)                                                                        Patients who have been infected with Covid-19 for at least 3 months                                                                                        People with long-term covid diagnosis, according to C19-YRSm tool                                                                                            Patients who have not participated in any other intervention or training and rehabilitation program at the same time      Individuals have no contraindications to exercise with a whole body vibration device (eg, vertigo, balance disorders, high blood pressure, severe osteoporosis, deep vein thrombosis, metal implants, pacemakers, epilepsy, tumors, arterial aneurysms, or arrhythmia)​</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>50 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Pregnant women                                                                                  Patients with previous psychological disorders or undergoing psychiatric treatment                                                                           Cardiovascular, neuromuscular and other systemic diseases or other diseases affecting physical activity                                          Any concurrent lung disease                                                               Patients who have suffered from other respiratory disease or other musculoskeletal disease during the last 12 months               Hearing and vision impairment that may interfere with the implementation of procedures                                                              Heart rate at rest, more than 100 beats per minute                          If the patient's peripheral capillary oxygen saturation (SpO2) is less than 88% and does not resolve with rest, or if the patient has persistent symptoms such as heart palpitations, sweating, and shortness of breath, and the doctor determines that rehabilitation is inappropriate for him                                                                        Other obstacles prohibiting the safety of sports                               Inability or unwillingness to continue cooperation in the study​</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>X, XIII, X</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Diseases of the respiratory system(X)، Diseases of the musculoskeletal system and connective tissue(XIII)، Factors influencing health status and contact with health services(XXI).</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Control group: pulmonary rehabilitation. In this study, for pulmonary rehabilitation, we will use breathing exercises, stretching exercises and resistance exercises with elastic band along with encouragement to carry out care recommendations at home, during 6 weeks and 3 sessions per week.​</i_keyword>
      <i_keyword>The first intervention group: pulmonary rehabilitation with whole body vibration. In this study, for lung rehabilitation, we will use breathing exercises, stretching exercises and resistance exercises with an elastic band along with encouragement to carry out care recommendations at home, during 6 weeks and 3 sessions per week, and in addition to exercise the total tremor. The body is made of lanaform brand, POWER FULLS model and model number LA 57665, made in Belgium. Each whole body vibration training session consists of ten sets of one minute, using the device with a frequency of 35 Hz, after each one minute of using the device, the person rests for one minute. The whole body vibration training is done in 12 sessions twice a week in the morning.</i_keyword>
      <i_keyword>The second intervention group: pulmonary rehabilitation with cognitive-behavioral therapy. In this study, we will use breathing exercises, stretching exercises and resistance exercises with an elastic band for pulmonary rehabilitation, along with encouraging to carry out care recommendations at home, during 6 weeks and 3 sessions per week, and in addition to cognitive behavioral therapy. Stark and Beck et al.'s model will be used. The sessions will be held in 6 weeks with 8 sessions (the first week (2 sessions), the second to fifth weeks (one session per week) and the last week (2 sessions)) for a duration of 45 minutes to one hour.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Fatigue score in the Fatigue severity scale questionnaire. Timepoint: Measurements will be done once before the intervention, once immediately after the intervention and again 2 months after the last  evaluation. Method of measurement: Fatigue severity scale questionnaire.</prim_outcome>
      <prim_outcome>Severity of shortness of breath in the Borg questionnaire. Timepoint: Measurements will be done once before the intervention, once immediately after the intervention and again 2 months after the last  evaluation. Method of measurement: Borg shortness of breath severity questionnaire.</prim_outcome>
      <prim_outcome>Quality of life score through quality of life questionnaire. Timepoint: Measurements will be done once before the intervention, once immediately after the intervention and again 2 months after the last  evaluation. Method of measurement: The 12-Item Short Form Health Survey (SF-12).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Iran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-10-07</approval_date>
        <contact_name>Ethics Committee of Iran University of Medical Sciences</contact_name>
        <contact_address>Faculty of Rehabilitation Sciences, Iran University of Medical Sciences, Maddkaran St., Shah Nazari St., Mader Square, Mirdamad, Tehran Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
